⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Eupraxia Pharmaceuticals Inc. Common Stock

$7.38
+0.30 (+4.16%)

Volume:

415.139K ($3.06M)

Market Capitalization:

$479.84M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Eupraxia Pharmaceuticals Market Segments

Overnight

*No Trades in Segment

After Hours

+0.00(+0.00%)
Open$7.38
Close$7.38
Low$7.38
Low Change0.00 (0.00%)
High$7.38
High Change+0.00 (+0.00%)
Range$0.00
Volume10.976K
Dollar Volume$81.00K

Regular Trading Hours

+0.29(+4.10%)
Open$7.08
Close$7.37
Low$6.90
Low Change-0.18 (-2.54%)
High$7.42
High Change+0.34 (+4.80%)
Range$0.52
Volume404.163K
Dollar Volume$2.98M

Premarket

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$7.08
Close$7.08
Low$7.08
Low Change0.00 (0.00%)
High$7.08
High Change+0.00 (+0.00%)
Range$0.00
Volume16.992K
Dollar Volume$120.30K

Regular Trading Hours Yesterday

+0.19(+2.68%)
Open$6.90
Close$7.09
Low$6.64
Low Change-0.26 (-3.77%)
High$7.16
High Change+0.26 (+3.77%)
Range$0.52
Volume457.33K
Dollar Volume$3.24M

Premarket Yesterday

*No Trades in Segment

Eupraxia Pharmaceuticals Top Trades

Eupraxia Pharmaceuticals's top trade so far today returned +6.96%, while the top short trade returned -2.54%.

Eupraxia Pharmaceuticals Moving Averages

5 Day Moving Average (SMA5)$7.22
10 Day Moving Average (SMA10)$7.07
20 Day Moving Average (SMA20)$7.36
50 Day Moving Average (SMA50)$7.58
100 Day Moving Average (SMA100)$7.00
200 Day Moving Average (SMA200)$7.33

Eupraxia Pharmaceuticals Statistics

Average Volume (30 Days)—
P/E Ratio (Current)—
EPS (Current)—
Dividend Yield—
Free Cash Flow—
Cash Ratio—
Current Ratio—
Quick Ratio—
Debt to Equity—
Enterprise Value—
EV to EBITDA—
EV to Sales—
Price to Book—
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales—
Return on Assets—
Return on Equity—

Eupraxia Pharmaceuticals Stock Splits

There have been no stock splits for Eupraxia Pharmaceuticals (EPRX).

Eupraxia Pharmaceuticals Dividends

There have been no dividends for Eupraxia Pharmaceuticals (EPRX).